Tag: Southpoint

spot_img

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

Article content NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) — Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, pursuant to securities laws, it disposed of beneficial ownership of 1,000,000 common shares (a “Common Share”) of Fennec Pharmaceuticals Inc.

Newsletter

Don't miss